Recall
FDAHealthJuly 30, 2025

GenoGenix LLC — BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manu

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 30, 2025

US Nationwide.

What's affected?

Product
BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).
Lot code
GG020525-001

Additional details

Lot#: GG020525-001, GG060525-001, GG062625-004, within expiry.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.